Borrelia Burgdorferi Nucleic Acid Detection Kit (Fluorescence PCR)

For in-vitro qualitative detection of Borrelia burgdorferi nucleic acid in whole blood, used as an auxiliary diagnostic aid for Lyme disease.

SKU Code
AENE-OT076
Approval
On request
Product Type
Assay / Kit
Status
Available

For in-vitro qualitative detection of Borrelia burgdorferi nucleic acid in whole blood, used as an auxiliary diagnostic aid for Lyme disease.

Product typeAssay / Kit
Technology platformFluorescence PCR
Application areaOthers

Certificate

CE

Epidemiology

Lyme disease results from Borrelia burgdorferi infection, primarily transmitted among animal hosts and to humans via hard ticks. The pathogen leads to erythema migrans and can affect multiple systems, including cardiac, neurological, and articular, with varied clinical presentations. Disease progression is categorized into early localized, early disseminated, and late persistent stages, all of which pose significant health risks. Consequently, developing a straightforward, specific, and rapid method for the etiological diagnosis of B. burgdorferi is critically important in clinical settings.

Work Flow

Option 1.

Use a silica membrane-based DNA blood midi kit for extraction, following the manufacturer's protocol precisely; elute in 100 µL.

Option 2.

Employ a blood genomic DNA extraction kit (catalog DP318, regulatory number 20210062) and follow the instructions strictly, with an elution volume of 100 µL.

Option 3.

Utilize a genomic DNA purification kit (catalog A1120), adhering to the manufacturer's guidelines, and elute in 100 µL.

SKU codeAENE-OT076
Storage≤-18℃
Shelf-life12 months
Specimen TypeWhole blood sample
Tt≤38
CV≤5.0%
LoD500 Copies/mL
Applicable InstrumentsABI 7500 Real-Time PCR Systems ABI 7500 Fast Real-Time PCR Systems QuantStudio ® 5 Real-Time PCR Systems SLAN-96P Real-Time PCR Systems LightCycler ® 480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System
ApprovalOn request
DocumentsDatasheet, IFU, SDS, COA / conformance, origin, and export documents where available

FAQ

What should be confirmed before quotation?

Sample context, collection method, and extraction workflow should be confirmed before final kit selection.

Which documents can be requested?

Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.

Can the format be adjusted for different workflows?

Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.

Send the essentials for a useful first reply.

Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-OT076 to the right quote or sample discussion.